Penumbra (PEN) Free Cash Flow (2014 - 2026)
Penumbra (PEN) posted quarterly Free Cash Flow of $32.5 million for Q2 2026, up 10.81% year-over-year from $29.4 million in Q2 2025, and down 55.6% quarter-over-quarter from $73.3 million in Q1 2026.
Penumbra (PEN) Free Cash Flow (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Free Cash Flow for 13 consecutive years, with $32.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Free Cash Flow rose 10.81% year-over-year to $32.5 million; the TTM figure through Jun 2026 stood at $215.9 million (up 33.59% YoY), while the FY2025 annual figure was $174.9 million, up 18.76% from the prior year.
- Free Cash Flow fell to $32.5 million in Q2 2026 per PEN's latest filing, from $73.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $73.3 million in Q1 2026 and bottomed at -$44.0 million in Q2 2022.
- Historically, Free Cash Flow has averaged $24.2 million across 5 years, with a median of $30.9 million in 2024.
- Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 566.25% — and 2023, when it surged 1565.89%.
- Penumbra's Free Cash Flow stood at -$2.2 million in 2022, then soared by 1565.89% to $32.6 million in 2023, then surged by 40.23% to $45.7 million in 2024, then soared by 48.79% to $68.0 million in 2025, then slumped by 52.18% to $32.5 million in 2026.
- Business Quant data shows PEN's Free Cash Flow at $32.5 million in Q2 2026, $73.3 million in Q1 2026, and $68.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Penumbra | 12.80 Bn | 12.14 Bn | 264.94 Mn | 32.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.54 Mn |
| Jun 30, 2026 | 32.54 Mn |
| Mar 31, 2026 | 75.19 Mn |
| Mar 31, 2026 | 75.19 Mn |
| Dec 31, 2025 | 82.74 Mn |
| Dec 31, 2025 | 82.74 Mn |
| Sep 30, 2025 | 85.76 Mn |
| Sep 30, 2025 | 85.76 Mn |
| Jun 30, 2025 | 17.63 Mn |
| Jun 30, 2025 | 17.63 Mn |
| Mar 31, 2025 | 47.24 Mn |
| Mar 31, 2025 | 47.24 Mn |
| Dec 31, 2024 | 45.74 Mn |
| Dec 31, 2024 | 45.74 Mn |
| Sep 30, 2024 | 51.02 Mn |
| Sep 30, 2024 | 51.02 Mn |
| Jun 30, 2024 | 18.08 Mn |
| Jun 30, 2024 | 18.08 Mn |
| Mar 31, 2024 | 32.47 Mn |
| Mar 31, 2024 | 32.47 Mn |